nodes	percent_of_prediction	percent_of_DWPC	metapath
Diphenhydramine—SLC22A2—Vinblastine—lung cancer	0.0678	0.108	CbGbCtD
Diphenhydramine—SLC22A2—Cisplatin—lung cancer	0.0622	0.0987	CbGbCtD
Diphenhydramine—CYP2C19—Gefitinib—lung cancer	0.0471	0.0748	CbGbCtD
Diphenhydramine—CYP2C19—Teniposide—lung cancer	0.0457	0.0726	CbGbCtD
Diphenhydramine—PTGS1—Etoposide—lung cancer	0.0416	0.0661	CbGbCtD
Diphenhydramine—CYP2B6—Irinotecan—lung cancer	0.0396	0.0629	CbGbCtD
Diphenhydramine—CYP2C9—Gefitinib—lung cancer	0.0392	0.0622	CbGbCtD
Diphenhydramine—CYP2C9—Teniposide—lung cancer	0.038	0.0603	CbGbCtD
Diphenhydramine—CYP2D6—Gefitinib—lung cancer	0.0358	0.0569	CbGbCtD
Diphenhydramine—CYP2B6—Cisplatin—lung cancer	0.0323	0.0513	CbGbCtD
Diphenhydramine—CYP2D6—Vinorelbine—lung cancer	0.0276	0.0438	CbGbCtD
Diphenhydramine—CYP1A2—Erlotinib—lung cancer	0.0257	0.0408	CbGbCtD
Diphenhydramine—CYP2B6—Doxorubicin—lung cancer	0.0216	0.0344	CbGbCtD
Diphenhydramine—CYP2C9—Paclitaxel—lung cancer	0.0212	0.0337	CbGbCtD
Diphenhydramine—CYP2D6—Erlotinib—lung cancer	0.0212	0.0336	CbGbCtD
Diphenhydramine—CYP1A2—Etoposide—lung cancer	0.0186	0.0295	CbGbCtD
Diphenhydramine—CYP2C9—Cisplatin—lung cancer	0.0171	0.0271	CbGbCtD
Diphenhydramine—CYP2D6—Vinblastine—lung cancer	0.017	0.027	CbGbCtD
Diphenhydramine—CYP2D6—Doxorubicin—lung cancer	0.0104	0.0166	CbGbCtD
Diphenhydramine—Levomethadyl Acetate—CHRNB4—lung cancer	0.001	0.135	CrCbGaD
Diphenhydramine—Levomethadyl Acetate—CHRNA3—lung cancer	0.000695	0.0935	CrCbGaD
Diphenhydramine—Vertigo—Irinotecan—lung cancer	0.000446	0.00249	CcSEcCtD
Diphenhydramine—Paraesthesia—Vinorelbine—lung cancer	0.000441	0.00247	CcSEcCtD
Diphenhydramine—Tinnitus—Paclitaxel—lung cancer	0.000434	0.00242	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Docetaxel—lung cancer	0.000431	0.00241	CcSEcCtD
Diphenhydramine—Decreased appetite—Vinorelbine—lung cancer	0.000427	0.00239	CcSEcCtD
Diphenhydramine—Chills—Etoposide—lung cancer	0.000426	0.00238	CcSEcCtD
Diphenhydramine—Vision blurred—Cisplatin—lung cancer	0.000425	0.00238	CcSEcCtD
Diphenhydramine—Asthenia—Vinblastine—lung cancer	0.000424	0.00237	CcSEcCtD
Diphenhydramine—Fatigue—Vinorelbine—lung cancer	0.000424	0.00237	CcSEcCtD
Diphenhydramine—Tremor—Cisplatin—lung cancer	0.000422	0.00236	CcSEcCtD
Diphenhydramine—Constipation—Vinorelbine—lung cancer	0.00042	0.00235	CcSEcCtD
Diphenhydramine—Chills—Paclitaxel—lung cancer	0.000417	0.00233	CcSEcCtD
Diphenhydramine—Asthenia—Topotecan—lung cancer	0.000412	0.0023	CcSEcCtD
Diphenhydramine—Agranulocytosis—Docetaxel—lung cancer	0.00041	0.00229	CcSEcCtD
Diphenhydramine—Confusional state—Irinotecan—lung cancer	0.000409	0.00228	CcSEcCtD
Diphenhydramine—Asthenia—Erlotinib—lung cancer	0.000408	0.00228	CcSEcCtD
Diphenhydramine—Photosensitivity—Doxorubicin—lung cancer	0.000405	0.00226	CcSEcCtD
Diphenhydramine—Feeling abnormal—Vinorelbine—lung cancer	0.000405	0.00226	CcSEcCtD
Diphenhydramine—Diarrhoea—Vinblastine—lung cancer	0.000405	0.00226	CcSEcCtD
Diphenhydramine—Tension—Paclitaxel—lung cancer	0.000397	0.00222	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Irinotecan—lung cancer	0.000397	0.00222	CcSEcCtD
Diphenhydramine—Nervousness—Paclitaxel—lung cancer	0.000393	0.0022	CcSEcCtD
Diphenhydramine—Diarrhoea—Topotecan—lung cancer	0.000393	0.0022	CcSEcCtD
Diphenhydramine—Irritability—Methotrexate—lung cancer	0.000392	0.00219	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Irinotecan—lung cancer	0.000392	0.00219	CcSEcCtD
Diphenhydramine—Dizziness—Vinblastine—lung cancer	0.000391	0.00219	CcSEcCtD
Diphenhydramine—Convulsion—Cisplatin—lung cancer	0.000391	0.00218	CcSEcCtD
Diphenhydramine—Urticaria—Vinorelbine—lung cancer	0.00039	0.00218	CcSEcCtD
Diphenhydramine—Diarrhoea—Erlotinib—lung cancer	0.000389	0.00217	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Gemcitabine—lung cancer	0.000386	0.00216	CcSEcCtD
Diphenhydramine—Anorexia—Irinotecan—lung cancer	0.000386	0.00216	CcSEcCtD
Diphenhydramine—Vision blurred—Paclitaxel—lung cancer	0.000382	0.00213	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Gemcitabine—lung cancer	0.000382	0.00213	CcSEcCtD
Diphenhydramine—Dizziness—Topotecan—lung cancer	0.00038	0.00212	CcSEcCtD
Diphenhydramine—Tremor—Paclitaxel—lung cancer	0.000379	0.00212	CcSEcCtD
Diphenhydramine—Hypotension—Irinotecan—lung cancer	0.000379	0.00212	CcSEcCtD
Diphenhydramine—Anorexia—Gemcitabine—lung cancer	0.000376	0.0021	CcSEcCtD
Diphenhydramine—Vomiting—Vinblastine—lung cancer	0.000376	0.0021	CcSEcCtD
Diphenhydramine—Dizziness—Erlotinib—lung cancer	0.000376	0.0021	CcSEcCtD
Diphenhydramine—Clomifene—CYP2A6—lung cancer	0.000376	0.0505	CrCbGaD
Diphenhydramine—Agitation—Paclitaxel—lung cancer	0.000372	0.00208	CcSEcCtD
Diphenhydramine—Vertigo—Etoposide—lung cancer	0.000371	0.00207	CcSEcCtD
Diphenhydramine—Headache—Vinblastine—lung cancer	0.00037	0.00207	CcSEcCtD
Diphenhydramine—Hypotension—Gemcitabine—lung cancer	0.000369	0.00206	CcSEcCtD
Diphenhydramine—Insomnia—Irinotecan—lung cancer	0.000366	0.00205	CcSEcCtD
Diphenhydramine—Vomiting—Topotecan—lung cancer	0.000365	0.00204	CcSEcCtD
Diphenhydramine—Paraesthesia—Irinotecan—lung cancer	0.000364	0.00203	CcSEcCtD
Diphenhydramine—Vertigo—Paclitaxel—lung cancer	0.000364	0.00203	CcSEcCtD
Diphenhydramine—Rash—Topotecan—lung cancer	0.000362	0.00202	CcSEcCtD
Diphenhydramine—Dermatitis—Topotecan—lung cancer	0.000362	0.00202	CcSEcCtD
Diphenhydramine—Vomiting—Erlotinib—lung cancer	0.000361	0.00202	CcSEcCtD
Diphenhydramine—Somnolence—Irinotecan—lung cancer	0.00036	0.00201	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Cisplatin—lung cancer	0.00036	0.00201	CcSEcCtD
Diphenhydramine—Headache—Topotecan—lung cancer	0.00036	0.00201	CcSEcCtD
Diphenhydramine—Tachycardia—Cisplatin—lung cancer	0.000359	0.00201	CcSEcCtD
Diphenhydramine—Rash—Erlotinib—lung cancer	0.000358	0.002	CcSEcCtD
Diphenhydramine—Dermatitis—Erlotinib—lung cancer	0.000358	0.002	CcSEcCtD
Diphenhydramine—Palpitations—Paclitaxel—lung cancer	0.000358	0.002	CcSEcCtD
Diphenhydramine—Convulsion—Etoposide—lung cancer	0.000358	0.002	CcSEcCtD
Diphenhydramine—Insomnia—Gemcitabine—lung cancer	0.000357	0.002	CcSEcCtD
Diphenhydramine—Dyspepsia—Irinotecan—lung cancer	0.000357	0.00199	CcSEcCtD
Diphenhydramine—Headache—Erlotinib—lung cancer	0.000356	0.00199	CcSEcCtD
Diphenhydramine—Diplopia—Doxorubicin—lung cancer	0.000356	0.00199	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Cisplatin—lung cancer	0.000356	0.00199	CcSEcCtD
Diphenhydramine—Paraesthesia—Gemcitabine—lung cancer	0.000354	0.00198	CcSEcCtD
Diphenhydramine—Chills—Docetaxel—lung cancer	0.000354	0.00198	CcSEcCtD
Diphenhydramine—Asthenia—Vinorelbine—lung cancer	0.000353	0.00197	CcSEcCtD
Diphenhydramine—Decreased appetite—Irinotecan—lung cancer	0.000352	0.00197	CcSEcCtD
Diphenhydramine—Nausea—Vinblastine—lung cancer	0.000351	0.00196	CcSEcCtD
Diphenhydramine—Somnolence—Gemcitabine—lung cancer	0.000351	0.00196	CcSEcCtD
Diphenhydramine—Convulsion—Paclitaxel—lung cancer	0.000351	0.00196	CcSEcCtD
Diphenhydramine—Anorexia—Cisplatin—lung cancer	0.000351	0.00196	CcSEcCtD
Diphenhydramine—Fatigue—Irinotecan—lung cancer	0.000349	0.00195	CcSEcCtD
Diphenhydramine—Constipation—Irinotecan—lung cancer	0.000347	0.00194	CcSEcCtD
Diphenhydramine—Hypotension—Cisplatin—lung cancer	0.000344	0.00192	CcSEcCtD
Diphenhydramine—Decreased appetite—Gemcitabine—lung cancer	0.000343	0.00192	CcSEcCtD
Diphenhydramine—Nausea—Topotecan—lung cancer	0.000341	0.00191	CcSEcCtD
Diphenhydramine—Fatigue—Gemcitabine—lung cancer	0.00034	0.0019	CcSEcCtD
Diphenhydramine—Confusional state—Etoposide—lung cancer	0.00034	0.0019	CcSEcCtD
Diphenhydramine—Constipation—Gemcitabine—lung cancer	0.000338	0.00189	CcSEcCtD
Diphenhydramine—Nausea—Erlotinib—lung cancer	0.000338	0.00189	CcSEcCtD
Diphenhydramine—Dry mouth—Paclitaxel—lung cancer	0.000337	0.00189	CcSEcCtD
Diphenhydramine—Diarrhoea—Vinorelbine—lung cancer	0.000336	0.00188	CcSEcCtD
Diphenhydramine—Feeling abnormal—Irinotecan—lung cancer	0.000334	0.00187	CcSEcCtD
Diphenhydramine—Confusional state—Paclitaxel—lung cancer	0.000333	0.00186	CcSEcCtD
Diphenhydramine—Dysuria—Methotrexate—lung cancer	0.000332	0.00186	CcSEcCtD
Diphenhydramine—Paraesthesia—Cisplatin—lung cancer	0.00033	0.00185	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Etoposide—lung cancer	0.00033	0.00185	CcSEcCtD
Diphenhydramine—Tachycardia—Etoposide—lung cancer	0.000329	0.00184	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Etoposide—lung cancer	0.000326	0.00182	CcSEcCtD
Diphenhydramine—Feeling abnormal—Gemcitabine—lung cancer	0.000325	0.00182	CcSEcCtD
Diphenhydramine—Dizziness—Vinorelbine—lung cancer	0.000325	0.00182	CcSEcCtD
Diphenhydramine—Photosensitivity reaction—Methotrexate—lung cancer	0.000324	0.00181	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Paclitaxel—lung cancer	0.000324	0.00181	CcSEcCtD
Diphenhydramine—Tachycardia—Paclitaxel—lung cancer	0.000323	0.0018	CcSEcCtD
Diphenhydramine—Anorexia—Etoposide—lung cancer	0.000321	0.0018	CcSEcCtD
Diphenhydramine—Decreased appetite—Cisplatin—lung cancer	0.00032	0.00179	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Paclitaxel—lung cancer	0.000319	0.00179	CcSEcCtD
Diphenhydramine—Drowsiness—Methotrexate—lung cancer	0.000317	0.00177	CcSEcCtD
Diphenhydramine—Anorexia—Paclitaxel—lung cancer	0.000315	0.00176	CcSEcCtD
Diphenhydramine—Hypotension—Etoposide—lung cancer	0.000315	0.00176	CcSEcCtD
Diphenhydramine—Vomiting—Vinorelbine—lung cancer	0.000312	0.00175	CcSEcCtD
Diphenhydramine—Rash—Vinorelbine—lung cancer	0.00031	0.00173	CcSEcCtD
Diphenhydramine—Dermatitis—Vinorelbine—lung cancer	0.00031	0.00173	CcSEcCtD
Diphenhydramine—Hypotension—Paclitaxel—lung cancer	0.000309	0.00173	CcSEcCtD
Diphenhydramine—Headache—Vinorelbine—lung cancer	0.000308	0.00172	CcSEcCtD
Diphenhydramine—Toremifene—CYP1A1—lung cancer	0.000304	0.041	CrCbGaD
Diphenhydramine—Palpitations—Docetaxel—lung cancer	0.000303	0.0017	CcSEcCtD
Diphenhydramine—Feeling abnormal—Cisplatin—lung cancer	0.000303	0.0017	CcSEcCtD
Diphenhydramine—Paraesthesia—Etoposide—lung cancer	0.000303	0.00169	CcSEcCtD
Diphenhydramine—Somnolence—Etoposide—lung cancer	0.0003	0.00168	CcSEcCtD
Diphenhydramine—Insomnia—Paclitaxel—lung cancer	0.000299	0.00167	CcSEcCtD
Diphenhydramine—Convulsion—Docetaxel—lung cancer	0.000297	0.00166	CcSEcCtD
Diphenhydramine—Paraesthesia—Paclitaxel—lung cancer	0.000297	0.00166	CcSEcCtD
Diphenhydramine—Agranulocytosis—Methotrexate—lung cancer	0.000295	0.00165	CcSEcCtD
Diphenhydramine—Somnolence—Paclitaxel—lung cancer	0.000294	0.00164	CcSEcCtD
Diphenhydramine—Decreased appetite—Etoposide—lung cancer	0.000293	0.00164	CcSEcCtD
Diphenhydramine—Nausea—Vinorelbine—lung cancer	0.000292	0.00163	CcSEcCtD
Diphenhydramine—Dyspepsia—Paclitaxel—lung cancer	0.000291	0.00163	CcSEcCtD
Diphenhydramine—Asthenia—Irinotecan—lung cancer	0.000291	0.00163	CcSEcCtD
Diphenhydramine—Fatigue—Etoposide—lung cancer	0.000291	0.00162	CcSEcCtD
Diphenhydramine—Constipation—Etoposide—lung cancer	0.000288	0.00161	CcSEcCtD
Diphenhydramine—Dysuria—Doxorubicin—lung cancer	0.000287	0.00161	CcSEcCtD
Diphenhydramine—Decreased appetite—Paclitaxel—lung cancer	0.000287	0.00161	CcSEcCtD
Diphenhydramine—Dry mouth—Docetaxel—lung cancer	0.000286	0.0016	CcSEcCtD
Diphenhydramine—Fatigue—Paclitaxel—lung cancer	0.000285	0.00159	CcSEcCtD
Diphenhydramine—Pollakiuria—Doxorubicin—lung cancer	0.000284	0.00159	CcSEcCtD
Diphenhydramine—Asthenia—Gemcitabine—lung cancer	0.000283	0.00158	CcSEcCtD
Diphenhydramine—Constipation—Paclitaxel—lung cancer	0.000283	0.00158	CcSEcCtD
Diphenhydramine—Confusional state—Docetaxel—lung cancer	0.000282	0.00158	CcSEcCtD
Diphenhydramine—Photosensitivity reaction—Doxorubicin—lung cancer	0.000281	0.00157	CcSEcCtD
Diphenhydramine—Feeling abnormal—Etoposide—lung cancer	0.000278	0.00155	CcSEcCtD
Diphenhydramine—Bifonazole—CYP2E1—lung cancer	0.000277	0.0373	CrCbGaD
Diphenhydramine—Diarrhoea—Irinotecan—lung cancer	0.000277	0.00155	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Docetaxel—lung cancer	0.000274	0.00153	CcSEcCtD
Diphenhydramine—Drowsiness—Doxorubicin—lung cancer	0.000274	0.00153	CcSEcCtD
Diphenhydramine—Tachycardia—Docetaxel—lung cancer	0.000273	0.00153	CcSEcCtD
Diphenhydramine—Feeling abnormal—Paclitaxel—lung cancer	0.000272	0.00152	CcSEcCtD
Diphenhydramine—Diarrhoea—Gemcitabine—lung cancer	0.00027	0.00151	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Doxorubicin—lung cancer	0.000269	0.0015	CcSEcCtD
Diphenhydramine—Dizziness—Irinotecan—lung cancer	0.000268	0.0015	CcSEcCtD
Diphenhydramine—Urticaria—Etoposide—lung cancer	0.000268	0.0015	CcSEcCtD
Diphenhydramine—Anorexia—Docetaxel—lung cancer	0.000267	0.00149	CcSEcCtD
Diphenhydramine—Clomifene—CYP2E1—lung cancer	0.000267	0.0359	CrCbGaD
Diphenhydramine—Tinnitus—Methotrexate—lung cancer	0.000265	0.00148	CcSEcCtD
Diphenhydramine—Asthenia—Cisplatin—lung cancer	0.000264	0.00148	CcSEcCtD
Diphenhydramine—Clomifene—CYP1A1—lung cancer	0.000263	0.0354	CrCbGaD
Diphenhydramine—Urticaria—Paclitaxel—lung cancer	0.000263	0.00147	CcSEcCtD
Diphenhydramine—Hypotension—Docetaxel—lung cancer	0.000262	0.00146	CcSEcCtD
Diphenhydramine—Vomiting—Irinotecan—lung cancer	0.000258	0.00144	CcSEcCtD
Diphenhydramine—Agranulocytosis—Doxorubicin—lung cancer	0.000256	0.00143	CcSEcCtD
Diphenhydramine—Rash—Irinotecan—lung cancer	0.000255	0.00143	CcSEcCtD
Diphenhydramine—Dermatitis—Irinotecan—lung cancer	0.000255	0.00143	CcSEcCtD
Diphenhydramine—Chills—Methotrexate—lung cancer	0.000255	0.00143	CcSEcCtD
Diphenhydramine—Headache—Irinotecan—lung cancer	0.000254	0.00142	CcSEcCtD
Diphenhydramine—Insomnia—Docetaxel—lung cancer	0.000253	0.00142	CcSEcCtD
Diphenhydramine—Diarrhoea—Cisplatin—lung cancer	0.000252	0.00141	CcSEcCtD
Diphenhydramine—Paraesthesia—Docetaxel—lung cancer	0.000252	0.00141	CcSEcCtD
Diphenhydramine—Vomiting—Gemcitabine—lung cancer	0.000251	0.0014	CcSEcCtD
Diphenhydramine—Somnolence—Docetaxel—lung cancer	0.000249	0.00139	CcSEcCtD
Diphenhydramine—Rash—Gemcitabine—lung cancer	0.000249	0.00139	CcSEcCtD
Diphenhydramine—Dermatitis—Gemcitabine—lung cancer	0.000249	0.00139	CcSEcCtD
Diphenhydramine—Cinnarizine—CYP2A6—lung cancer	0.000248	0.0334	CrCbGaD
Diphenhydramine—Headache—Gemcitabine—lung cancer	0.000247	0.00138	CcSEcCtD
Diphenhydramine—Dyspepsia—Docetaxel—lung cancer	0.000247	0.00138	CcSEcCtD
Diphenhydramine—Decreased appetite—Docetaxel—lung cancer	0.000243	0.00136	CcSEcCtD
Diphenhydramine—Asthenia—Etoposide—lung cancer	0.000242	0.00135	CcSEcCtD
Diphenhydramine—Fatigue—Docetaxel—lung cancer	0.000241	0.00135	CcSEcCtD
Diphenhydramine—Nausea—Irinotecan—lung cancer	0.000241	0.00135	CcSEcCtD
Diphenhydramine—Constipation—Docetaxel—lung cancer	0.00024	0.00134	CcSEcCtD
Diphenhydramine—Asthenia—Paclitaxel—lung cancer	0.000237	0.00133	CcSEcCtD
Diphenhydramine—Nausea—Gemcitabine—lung cancer	0.000234	0.00131	CcSEcCtD
Diphenhydramine—Vomiting—Cisplatin—lung cancer	0.000234	0.00131	CcSEcCtD
Diphenhydramine—Vision blurred—Methotrexate—lung cancer	0.000233	0.0013	CcSEcCtD
Diphenhydramine—Rash—Cisplatin—lung cancer	0.000232	0.0013	CcSEcCtD
Diphenhydramine—Dermatitis—Cisplatin—lung cancer	0.000232	0.0013	CcSEcCtD
Diphenhydramine—Feeling abnormal—Docetaxel—lung cancer	0.000231	0.00129	CcSEcCtD
Diphenhydramine—Diarrhoea—Etoposide—lung cancer	0.000231	0.00129	CcSEcCtD
Diphenhydramine—Tinnitus—Doxorubicin—lung cancer	0.000229	0.00128	CcSEcCtD
Diphenhydramine—Diarrhoea—Paclitaxel—lung cancer	0.000226	0.00126	CcSEcCtD
Diphenhydramine—Dizziness—Etoposide—lung cancer	0.000223	0.00125	CcSEcCtD
Diphenhydramine—Vertigo—Methotrexate—lung cancer	0.000222	0.00124	CcSEcCtD
Diphenhydramine—Chills—Doxorubicin—lung cancer	0.000221	0.00123	CcSEcCtD
Diphenhydramine—Warfarin—CYP1A1—lung cancer	0.000219	0.0295	CrCbGaD
Diphenhydramine—Carbinoxamine—CYP2E1—lung cancer	0.000219	0.0295	CrCbGaD
Diphenhydramine—Dizziness—Paclitaxel—lung cancer	0.000219	0.00122	CcSEcCtD
Diphenhydramine—Nausea—Cisplatin—lung cancer	0.000219	0.00122	CcSEcCtD
Diphenhydramine—Oxaprozin—PTGS2—lung cancer	0.000217	0.0292	CrCbGaD
Diphenhydramine—Convulsion—Methotrexate—lung cancer	0.000214	0.0012	CcSEcCtD
Diphenhydramine—Vomiting—Etoposide—lung cancer	0.000214	0.0012	CcSEcCtD
Diphenhydramine—Rash—Etoposide—lung cancer	0.000213	0.00119	CcSEcCtD
Diphenhydramine—Dermatitis—Etoposide—lung cancer	0.000212	0.00119	CcSEcCtD
Diphenhydramine—Headache—Etoposide—lung cancer	0.000211	0.00118	CcSEcCtD
Diphenhydramine—Tension—Doxorubicin—lung cancer	0.00021	0.00118	CcSEcCtD
Diphenhydramine—Vomiting—Paclitaxel—lung cancer	0.00021	0.00117	CcSEcCtD
Diphenhydramine—Rash—Paclitaxel—lung cancer	0.000208	0.00117	CcSEcCtD
Diphenhydramine—Dermatitis—Paclitaxel—lung cancer	0.000208	0.00116	CcSEcCtD
Diphenhydramine—Nervousness—Doxorubicin—lung cancer	0.000208	0.00116	CcSEcCtD
Diphenhydramine—Headache—Paclitaxel—lung cancer	0.000207	0.00116	CcSEcCtD
Diphenhydramine—Reboxetine—ABCB1—lung cancer	0.000204	0.0275	CrCbGaD
Diphenhydramine—Confusional state—Methotrexate—lung cancer	0.000204	0.00114	CcSEcCtD
Diphenhydramine—Vision blurred—Doxorubicin—lung cancer	0.000202	0.00113	CcSEcCtD
Diphenhydramine—Asthenia—Docetaxel—lung cancer	0.000201	0.00112	CcSEcCtD
Diphenhydramine—Nausea—Etoposide—lung cancer	0.0002	0.00112	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Methotrexate—lung cancer	0.000198	0.00111	CcSEcCtD
Diphenhydramine—Agitation—Doxorubicin—lung cancer	0.000197	0.0011	CcSEcCtD
Diphenhydramine—Nausea—Paclitaxel—lung cancer	0.000196	0.0011	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Methotrexate—lung cancer	0.000195	0.00109	CcSEcCtD
Diphenhydramine—Vertigo—Doxorubicin—lung cancer	0.000192	0.00108	CcSEcCtD
Diphenhydramine—Anorexia—Methotrexate—lung cancer	0.000192	0.00108	CcSEcCtD
Diphenhydramine—Diarrhoea—Docetaxel—lung cancer	0.000192	0.00107	CcSEcCtD
Diphenhydramine—Brompheniramine—CYP2E1—lung cancer	0.00019	0.0256	CrCbGaD
Diphenhydramine—Palpitations—Doxorubicin—lung cancer	0.000189	0.00106	CcSEcCtD
Diphenhydramine—Hypotension—Methotrexate—lung cancer	0.000189	0.00105	CcSEcCtD
Diphenhydramine—Convulsion—Doxorubicin—lung cancer	0.000186	0.00104	CcSEcCtD
Diphenhydramine—Dizziness—Docetaxel—lung cancer	0.000185	0.00104	CcSEcCtD
Diphenhydramine—Insomnia—Methotrexate—lung cancer	0.000183	0.00102	CcSEcCtD
Diphenhydramine—Paraesthesia—Methotrexate—lung cancer	0.000181	0.00101	CcSEcCtD
Diphenhydramine—Somnolence—Methotrexate—lung cancer	0.000179	0.001	CcSEcCtD
Diphenhydramine—Fenoprofen—PTGS2—lung cancer	0.000179	0.0241	CrCbGaD
Diphenhydramine—Dry mouth—Doxorubicin—lung cancer	0.000178	0.000997	CcSEcCtD
Diphenhydramine—Vomiting—Docetaxel—lung cancer	0.000178	0.000996	CcSEcCtD
Diphenhydramine—Dyspepsia—Methotrexate—lung cancer	0.000178	0.000994	CcSEcCtD
Diphenhydramine—Rash—Docetaxel—lung cancer	0.000177	0.000987	CcSEcCtD
Diphenhydramine—Dermatitis—Docetaxel—lung cancer	0.000176	0.000987	CcSEcCtD
Diphenhydramine—Confusional state—Doxorubicin—lung cancer	0.000176	0.000986	CcSEcCtD
Diphenhydramine—Decreased appetite—Methotrexate—lung cancer	0.000175	0.000981	CcSEcCtD
Diphenhydramine—Headache—Docetaxel—lung cancer	0.000175	0.000981	CcSEcCtD
Diphenhydramine—Fatigue—Methotrexate—lung cancer	0.000174	0.000973	CcSEcCtD
Diphenhydramine—Cinnarizine—CYP1A1—lung cancer	0.000174	0.0234	CrCbGaD
Diphenhydramine—Tamoxifen—CYP2A6—lung cancer	0.000174	0.0234	CrCbGaD
Diphenhydramine—Thrombocytopenia—Doxorubicin—lung cancer	0.000171	0.000957	CcSEcCtD
Diphenhydramine—Tachycardia—Doxorubicin—lung cancer	0.000171	0.000954	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Doxorubicin—lung cancer	0.000169	0.000945	CcSEcCtD
Diphenhydramine—Anorexia—Doxorubicin—lung cancer	0.000167	0.000932	CcSEcCtD
Diphenhydramine—Nausea—Docetaxel—lung cancer	0.000166	0.00093	CcSEcCtD
Diphenhydramine—Feeling abnormal—Methotrexate—lung cancer	0.000166	0.00093	CcSEcCtD
Diphenhydramine—Hypotension—Doxorubicin—lung cancer	0.000163	0.000913	CcSEcCtD
Diphenhydramine—Toremifene—ABCB1—lung cancer	0.000162	0.0218	CrCbGaD
Diphenhydramine—Urticaria—Methotrexate—lung cancer	0.00016	0.000897	CcSEcCtD
Diphenhydramine—Fenoprofen—ALB—lung cancer	0.00016	0.0215	CrCbGaD
Diphenhydramine—Insomnia—Doxorubicin—lung cancer	0.000158	0.000884	CcSEcCtD
Diphenhydramine—Paraesthesia—Doxorubicin—lung cancer	0.000157	0.000878	CcSEcCtD
Diphenhydramine—Somnolence—Doxorubicin—lung cancer	0.000155	0.000869	CcSEcCtD
Diphenhydramine—Tamoxifen—ABCG2—lung cancer	0.000155	0.0209	CrCbGaD
Diphenhydramine—Dyspepsia—Doxorubicin—lung cancer	0.000154	0.00086	CcSEcCtD
Diphenhydramine—Decreased appetite—Doxorubicin—lung cancer	0.000152	0.00085	CcSEcCtD
Diphenhydramine—Fatigue—Doxorubicin—lung cancer	0.000151	0.000843	CcSEcCtD
Diphenhydramine—Constipation—Doxorubicin—lung cancer	0.000149	0.000836	CcSEcCtD
Diphenhydramine—Asthenia—Methotrexate—lung cancer	0.000145	0.00081	CcSEcCtD
Diphenhydramine—Feeling abnormal—Doxorubicin—lung cancer	0.000144	0.000805	CcSEcCtD
Diphenhydramine—Phenylbutazone—PTGS2—lung cancer	0.000143	0.0193	CrCbGaD
Diphenhydramine—Clomifene—ABCB1—lung cancer	0.00014	0.0188	CrCbGaD
Diphenhydramine—Urticaria—Doxorubicin—lung cancer	0.000139	0.000776	CcSEcCtD
Diphenhydramine—Diarrhoea—Methotrexate—lung cancer	0.000138	0.000772	CcSEcCtD
Diphenhydramine—Phenprocoumon—ALB—lung cancer	0.000138	0.0185	CrCbGaD
Diphenhydramine—Dizziness—Methotrexate—lung cancer	0.000134	0.000746	CcSEcCtD
Diphenhydramine—Vomiting—Methotrexate—lung cancer	0.000128	0.000718	CcSEcCtD
Diphenhydramine—Rash—Methotrexate—lung cancer	0.000127	0.000712	CcSEcCtD
Diphenhydramine—Dermatitis—Methotrexate—lung cancer	0.000127	0.000711	CcSEcCtD
Diphenhydramine—Headache—Methotrexate—lung cancer	0.000126	0.000707	CcSEcCtD
Diphenhydramine—Asthenia—Doxorubicin—lung cancer	0.000125	0.000701	CcSEcCtD
Diphenhydramine—Tamoxifen—CYP2E1—lung cancer	0.000123	0.0166	CrCbGaD
Diphenhydramine—Warfarin—ALB—lung cancer	0.000122	0.0164	CrCbGaD
Diphenhydramine—Tamoxifen—CYP1A1—lung cancer	0.000122	0.0164	CrCbGaD
Diphenhydramine—Nausea—Methotrexate—lung cancer	0.00012	0.00067	CcSEcCtD
Diphenhydramine—Orphenadrine—CYP2E1—lung cancer	0.00012	0.0161	CrCbGaD
Diphenhydramine—Diarrhoea—Doxorubicin—lung cancer	0.00012	0.000669	CcSEcCtD
Diphenhydramine—Dizziness—Doxorubicin—lung cancer	0.000116	0.000646	CcSEcCtD
Diphenhydramine—Vomiting—Doxorubicin—lung cancer	0.000111	0.000621	CcSEcCtD
Diphenhydramine—Rash—Doxorubicin—lung cancer	0.00011	0.000616	CcSEcCtD
Diphenhydramine—Dermatitis—Doxorubicin—lung cancer	0.00011	0.000616	CcSEcCtD
Diphenhydramine—Headache—Doxorubicin—lung cancer	0.00011	0.000612	CcSEcCtD
Diphenhydramine—Nausea—Doxorubicin—lung cancer	0.000104	0.000581	CcSEcCtD
Diphenhydramine—Bepridil—ABCB1—lung cancer	0.000102	0.0137	CrCbGaD
Diphenhydramine—Imipramine—CYP2E1—lung cancer	9.56e-05	0.0129	CrCbGaD
Diphenhydramine—Amitriptyline—CYP2E1—lung cancer	9.5e-05	0.0128	CrCbGaD
Diphenhydramine—Fentanyl—ABCB1—lung cancer	9.34e-05	0.0126	CrCbGaD
Diphenhydramine—Phenytoin—ALB—lung cancer	8.88e-05	0.0119	CrCbGaD
Diphenhydramine—Phenytoin—ABCB1—lung cancer	8.47e-05	0.0114	CrCbGaD
Diphenhydramine—Trimipramine—ABCB1—lung cancer	6.76e-05	0.00909	CrCbGaD
Diphenhydramine—Promethazine—ABCB1—lung cancer	6.51e-05	0.00876	CrCbGaD
Diphenhydramine—Tamoxifen—ABCB1—lung cancer	6.46e-05	0.0087	CrCbGaD
Diphenhydramine—Doxepin—ABCB1—lung cancer	6.44e-05	0.00867	CrCbGaD
Diphenhydramine—Methadone—ABCB1—lung cancer	6.41e-05	0.00862	CrCbGaD
Diphenhydramine—Amitriptyline—ALB—lung cancer	5.22e-05	0.00702	CrCbGaD
Diphenhydramine—Imipramine—ABCB1—lung cancer	5.01e-05	0.00674	CrCbGaD
Diphenhydramine—Amitriptyline—ABCB1—lung cancer	4.98e-05	0.0067	CrCbGaD
Diphenhydramine—HRH1—Signaling by GPCR—CXCL8—lung cancer	1.06e-05	5.75e-05	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—CREBBP—lung cancer	1.05e-05	5.73e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—ERBB3—lung cancer	1.05e-05	5.71e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—NQO1—lung cancer	1.05e-05	5.7e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—CXCL8—lung cancer	1.04e-05	5.65e-05	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—POMC—lung cancer	1.04e-05	5.64e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—STK11—lung cancer	1.04e-05	5.64e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—ERBB3—lung cancer	1.03e-05	5.62e-05	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—PIK3CD—lung cancer	1.03e-05	5.59e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.03e-05	5.59e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.02e-05	5.53e-05	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—ALB—lung cancer	1.02e-05	5.52e-05	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—CREBBP—lung cancer	1.01e-05	5.5e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—ENO1—lung cancer	1.01e-05	5.5e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—IL2—lung cancer	1.01e-05	5.49e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.01e-05	5.48e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—TERT—lung cancer	1.01e-05	5.47e-05	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—PIK3CD—lung cancer	9.99e-06	5.43e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	9.95e-06	5.41e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—IL2—lung cancer	9.94e-06	5.4e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—TERT—lung cancer	9.91e-06	5.38e-05	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—ALB—lung cancer	9.86e-06	5.36e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—FGFR1—lung cancer	9.78e-06	5.31e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—lung cancer	9.74e-06	5.29e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—HIF1A—lung cancer	9.63e-06	5.23e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—FGFR1—lung cancer	9.62e-06	5.23e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—GSTP1—lung cancer	9.6e-06	5.22e-05	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PIK3CD—lung cancer	9.59e-06	5.21e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—STK11—lung cancer	9.55e-06	5.19e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—APOA1—lung cancer	9.5e-06	5.16e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—HIF1A—lung cancer	9.47e-06	5.15e-05	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—ALB—lung cancer	9.47e-06	5.15e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—STK11—lung cancer	9.46e-06	5.14e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—CAT—lung cancer	9.35e-06	5.08e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—APOA1—lung cancer	9.29e-06	5.05e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—lung cancer	9.29e-06	5.05e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—KDR—lung cancer	9.21e-06	5e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—APOA1—lung cancer	9.14e-06	4.97e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—ABCB1—lung cancer	9.09e-06	4.94e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CYP2E1—lung cancer	9.07e-06	4.93e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—KDR—lung cancer	9.06e-06	4.92e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—NQO1—lung cancer	8.97e-06	4.87e-05	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—PIK3CB—lung cancer	8.97e-06	4.87e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—TYMS—lung cancer	8.93e-06	4.85e-05	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—PTGS2—lung cancer	8.89e-06	4.83e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	8.88e-06	4.83e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—GSTP1—lung cancer	8.83e-06	4.8e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—GSTM1—lung cancer	8.83e-06	4.8e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	8.79e-06	4.77e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—GSTP1—lung cancer	8.76e-06	4.76e-05	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—PIK3CB—lung cancer	8.71e-06	4.73e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	8.7e-06	4.73e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PIK3CG—lung cancer	8.67e-06	4.71e-05	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—PTGS2—lung cancer	8.63e-06	4.69e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—CAT—lung cancer	8.6e-06	4.67e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—CAT—lung cancer	8.52e-06	4.63e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—KIT—lung cancer	8.48e-06	4.61e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—APC—lung cancer	8.48e-06	4.61e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PIK3CG—lung cancer	8.48e-06	4.61e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—NRAS—lung cancer	8.48e-06	4.61e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	8.47e-06	4.6e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—EGF—lung cancer	8.39e-06	4.56e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—CYP1A1—lung cancer	8.37e-06	4.55e-05	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PIK3CB—lung cancer	8.36e-06	4.54e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—ABCB1—lung cancer	8.36e-06	4.54e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PIK3CG—lung cancer	8.35e-06	4.54e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—KIT—lung cancer	8.35e-06	4.54e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—APC—lung cancer	8.35e-06	4.54e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—NRAS—lung cancer	8.35e-06	4.54e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—ERCC2—lung cancer	8.3e-06	4.51e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—ABCB1—lung cancer	8.29e-06	4.5e-05	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PTGS2—lung cancer	8.29e-06	4.5e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—POMC—lung cancer	8.25e-06	4.48e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—EGF—lung cancer	8.25e-06	4.48e-05	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—PIK3CA—lung cancer	8.24e-06	4.48e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—TYMS—lung cancer	8.21e-06	4.46e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—TYMS—lung cancer	8.14e-06	4.42e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—MAPK3—lung cancer	8.12e-06	4.41e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—GSTM1—lung cancer	8.12e-06	4.41e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—STK11—lung cancer	8.09e-06	4.39e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—POMC—lung cancer	8.07e-06	4.39e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—GSTM1—lung cancer	8.05e-06	4.37e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—CREBBP—lung cancer	8.04e-06	4.37e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—MAPK3—lung cancer	7.99e-06	4.34e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—BRAF—lung cancer	7.97e-06	4.33e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—POMC—lung cancer	7.95e-06	4.32e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—IL6R—lung cancer	7.88e-06	4.28e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CREBBP—lung cancer	7.86e-06	4.27e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—BRAF—lung cancer	7.85e-06	4.26e-05	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—PTEN—lung cancer	7.75e-06	4.21e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—IL6R—lung cancer	7.75e-06	4.21e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CREBBP—lung cancer	7.74e-06	4.2e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—EGFR—lung cancer	7.73e-06	4.2e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—CYP1A1—lung cancer	7.69e-06	4.18e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—ERCC2—lung cancer	7.63e-06	4.15e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—CYP1A1—lung cancer	7.63e-06	4.14e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PIK3CD—lung cancer	7.62e-06	4.14e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—EGFR—lung cancer	7.6e-06	4.13e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	7.59e-06	4.12e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—ERCC2—lung cancer	7.57e-06	4.11e-05	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—PTEN—lung cancer	7.53e-06	4.09e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—ALB—lung cancer	7.53e-06	4.09e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—MAP2K1—lung cancer	7.51e-06	4.08e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—GSTP1—lung cancer	7.48e-06	4.07e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PIK3CD—lung cancer	7.46e-06	4.05e-05	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—EP300—lung cancer	7.39e-06	4.02e-05	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—PIK3CA—lung cancer	7.39e-06	4.01e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—MAP2K1—lung cancer	7.39e-06	4.01e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PIK3CD—lung cancer	7.34e-06	3.99e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—KRAS—lung cancer	7.3e-06	3.97e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CAT—lung cancer	7.28e-06	3.96e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—PIK3CA—lung cancer	7.27e-06	3.95e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	7.24e-06	3.93e-05	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PTEN—lung cancer	7.23e-06	3.93e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—KRAS—lung cancer	7.18e-06	3.9e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—APOA1—lung cancer	7.18e-06	3.9e-05	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—EP300—lung cancer	7.18e-06	3.9e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—ABCB1—lung cancer	7.08e-06	3.85e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—TYMS—lung cancer	6.96e-06	3.78e-05	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—EP300—lung cancer	6.89e-06	3.74e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—GSTM1—lung cancer	6.88e-06	3.74e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	6.87e-06	3.73e-05	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—AKT1—lung cancer	6.73e-06	3.66e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—PIK3CA—lung cancer	6.71e-06	3.64e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—MDM2—lung cancer	6.68e-06	3.63e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—RAF1—lung cancer	6.66e-06	3.62e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PIK3CB—lung cancer	6.64e-06	3.61e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—APOA1—lung cancer	6.6e-06	3.59e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—PIK3CA—lung cancer	6.6e-06	3.59e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—ERBB2—lung cancer	6.59e-06	3.58e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PTGS2—lung cancer	6.58e-06	3.58e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—MDM2—lung cancer	6.57e-06	3.57e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PIK3CG—lung cancer	6.55e-06	3.56e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—RAF1—lung cancer	6.55e-06	3.56e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—APOA1—lung cancer	6.54e-06	3.56e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CYP1A1—lung cancer	6.52e-06	3.54e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PIK3CB—lung cancer	6.5e-06	3.53e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—MTOR—lung cancer	6.5e-06	3.53e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—ERBB2—lung cancer	6.48e-06	3.52e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—ERCC2—lung cancer	6.47e-06	3.51e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—MTOR—lung cancer	6.4e-06	3.48e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PIK3CB—lung cancer	6.4e-06	3.48e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	6.27e-06	3.41e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CXCL8—lung cancer	6.25e-06	3.39e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—POMC—lung cancer	6.24e-06	3.39e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—HRAS—lung cancer	6.21e-06	3.37e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CXCL8—lung cancer	6.15e-06	3.34e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—HRAS—lung cancer	6.11e-06	3.32e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—CREBBP—lung cancer	6.08e-06	3.3e-05	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—AKT1—lung cancer	6.03e-06	3.28e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PIK3CG—lung cancer	6.03e-06	3.27e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CASP3—lung cancer	5.98e-06	3.25e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PIK3CG—lung cancer	5.98e-06	3.25e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—IL2—lung cancer	5.97e-06	3.24e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—IL6—lung cancer	5.94e-06	3.23e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—AKT1—lung cancer	5.94e-06	3.23e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CASP3—lung cancer	5.88e-06	3.2e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—IL2—lung cancer	5.87e-06	3.19e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—IL6—lung cancer	5.84e-06	3.18e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CCND1—lung cancer	5.82e-06	3.16e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—JUN—lung cancer	5.81e-06	3.16e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PIK3CD—lung cancer	5.76e-06	3.13e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PTEN—lung cancer	5.74e-06	3.12e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—POMC—lung cancer	5.74e-06	3.12e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CCND1—lung cancer	5.73e-06	3.11e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—JUN—lung cancer	5.71e-06	3.1e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—POMC—lung cancer	5.69e-06	3.09e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—ALB—lung cancer	5.69e-06	3.09e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—MMP9—lung cancer	5.65e-06	3.07e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CDKN1A—lung cancer	5.63e-06	3.06e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PTEN—lung cancer	5.62e-06	3.05e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—APOA1—lung cancer	5.59e-06	3.04e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—CREBBP—lung cancer	5.59e-06	3.04e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—MMP9—lung cancer	5.56e-06	3.02e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—CREBBP—lung cancer	5.54e-06	3.01e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CDKN1A—lung cancer	5.54e-06	3.01e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PTEN—lung cancer	5.53e-06	3e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—AKT1—lung cancer	5.48e-06	2.98e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—EP300—lung cancer	5.48e-06	2.98e-05	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—PIK3CA—lung cancer	5.47e-06	2.97e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—AKT1—lung cancer	5.39e-06	2.93e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—EP300—lung cancer	5.36e-06	2.91e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	5.36e-06	2.91e-05	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—PIK3CA—lung cancer	5.31e-06	2.88e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PIK3CD—lung cancer	5.3e-06	2.88e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—EP300—lung cancer	5.27e-06	2.86e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PIK3CD—lung cancer	5.25e-06	2.85e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—ALB—lung cancer	5.23e-06	2.84e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—SRC—lung cancer	5.21e-06	2.83e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—ALB—lung cancer	5.19e-06	2.82e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—SRC—lung cancer	5.13e-06	2.78e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PIK3CG—lung cancer	5.11e-06	2.77e-05	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PIK3CA—lung cancer	5.1e-06	2.77e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—VEGFA—lung cancer	5.07e-06	2.76e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—STAT3—lung cancer	5.02e-06	2.73e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PIK3CB—lung cancer	5.02e-06	2.73e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—NRAS—lung cancer	5.01e-06	2.72e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—VEGFA—lung cancer	4.99e-06	2.71e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PTGS2—lung cancer	4.98e-06	2.7e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—STAT3—lung cancer	4.94e-06	2.69e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—NRAS—lung cancer	4.93e-06	2.68e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—POMC—lung cancer	4.86e-06	2.64e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—MAPK3—lung cancer	4.8e-06	2.61e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CREBBP—lung cancer	4.73e-06	2.57e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—MAPK3—lung cancer	4.72e-06	2.57e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—MYC—lung cancer	4.67e-06	2.54e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PIK3CB—lung cancer	4.62e-06	2.51e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—MYC—lung cancer	4.59e-06	2.5e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PIK3CB—lung cancer	4.58e-06	2.49e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PTGS2—lung cancer	4.58e-06	2.49e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—EGFR—lung cancer	4.57e-06	2.48e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PTGS2—lung cancer	4.54e-06	2.46e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—EGFR—lung cancer	4.49e-06	2.44e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PIK3CD—lung cancer	4.49e-06	2.44e-05	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—AKT1—lung cancer	4.47e-06	2.43e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—ALB—lung cancer	4.43e-06	2.41e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PTEN—lung cancer	4.34e-06	2.36e-05	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—AKT1—lung cancer	4.34e-06	2.36e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—KRAS—lung cancer	4.31e-06	2.34e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—KRAS—lung cancer	4.24e-06	2.31e-05	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—AKT1—lung cancer	4.16e-06	2.26e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—EP300—lung cancer	4.14e-06	2.25e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PIK3CA—lung cancer	4.05e-06	2.2e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PTEN—lung cancer	3.99e-06	2.17e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PIK3CA—lung cancer	3.96e-06	2.15e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PTEN—lung cancer	3.96e-06	2.15e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PIK3CB—lung cancer	3.91e-06	2.13e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PIK3CA—lung cancer	3.9e-06	2.12e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PTGS2—lung cancer	3.88e-06	2.11e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—TP53—lung cancer	3.83e-06	2.08e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—EP300—lung cancer	3.81e-06	2.07e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—EP300—lung cancer	3.77e-06	2.05e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—TP53—lung cancer	3.77e-06	2.05e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—HRAS—lung cancer	3.67e-06	1.99e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—HRAS—lung cancer	3.61e-06	1.96e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—IL6—lung cancer	3.51e-06	1.91e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—IL6—lung cancer	3.45e-06	1.88e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PTEN—lung cancer	3.38e-06	1.84e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—AKT1—lung cancer	3.31e-06	1.8e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—AKT1—lung cancer	3.24e-06	1.76e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—EP300—lung cancer	3.22e-06	1.75e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—AKT1—lung cancer	3.19e-06	1.73e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PIK3CA—lung cancer	3.06e-06	1.66e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PIK3CA—lung cancer	2.82e-06	1.53e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PIK3CA—lung cancer	2.79e-06	1.52e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—AKT1—lung cancer	2.5e-06	1.36e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PIK3CA—lung cancer	2.39e-06	1.3e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—AKT1—lung cancer	2.3e-06	1.25e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—AKT1—lung cancer	2.28e-06	1.24e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—AKT1—lung cancer	1.95e-06	1.06e-05	CbGpPWpGaD
